Gavin Malenfant
Chief Operating Officer chez PROMIS NEUROSCIENCES, INC.
Fortune : 5 081 $ au 31/03/2024
Profil
Gavin T.
Malenfant is the founder of GMalenfant Consulting LLC, which was founded in 2018.
He is currently the Chief Operating Officer at ProMIS Neurosciences, Inc. since 2021.
Previously, he worked as the Head-Operations & Vice President at Sarepta Therapeutics, Inc. from 2015 to 2016, and as the Head-Corporate Operations & Program Management at Akebia Therapeutics, Inc. from 2016 to 2018.
He also worked at Genzyme Corp.
as the Head-Operations.
Mr. Malenfant received his undergraduate degree from the University of Massachusetts Boston.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/10/2023 | 2 660 ( 0,01% ) | 5 081 $ | 31/03/2024 |
Postes actifs de Gavin Malenfant
| Sociétés | Poste | Début |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Chief Operating Officer | 22/10/2021 |
Anciens postes connus de Gavin Malenfant
| Sociétés | Poste | Fin |
|---|---|---|
| GMalenfant Consulting LLC | Founder | 01/10/2021 |
| AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2018 |
| SAREPTA THERAPEUTICS, INC. | Chief Operating Officer | 01/01/2016 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Chief Operating Officer | - |
Formation de Gavin Malenfant
| University of Massachusetts Boston | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| PROMIS NEUROSCIENCES, INC. | Health Technology |
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| GMalenfant Consulting LLC |
